The Baerveldt Versus Paul (BvP) Study is a Registry-based Randomised Controlled Trial, Comparing the Baerveldt Glaucoma Implant (BGI) and the Paul Glaucoma Implant (PGI). Participants will Include patients requiring aqueous shunt surgery for control of intraocular pressure and glaucoma.
The objective of this study is to compare the long-term safety and effectiveness of placement of a BGI and PGI for patients who are undergoing aqueous shunt implant surgery. Patients who qualify for the study are randomized to receive either a BGI or PGI aqueous shunt.
Inclusion Criteria:
Exclusion Criteria:
eamonn.fahy@sydney.edu.au+61 2 9382 7111
Patients randomised to this arm will undergo insertion of a Baerveldt Glaucoma Implant.
Patients randomised to this arm will undergo insertion of a Paul Glaucoma Implant.
Sydney, New South Wales 2000, Australia
eamonn.fahy@sydney.edu.au+61 2 9382 7111
eamonn.fahy@sydney.edu.au+61 2 8890 5555
eamonn.fahy@sydney.edu.au+61 2 8378 3000
info@eyeandear.org.au+61 3 9929 8666
The AVB Study: Prospective Study Comparing the Ahmed Valve and the Baerveldt Implant for Treating Refractory Glaucoma
Bicuspid Aortic Valve Replacement: Evaluation of Transcatheter Versus Surgery-Pilot Trial
GORE VIABAHN® Versus Plain Old Balloon Angioplasty (POBA) for Superficial Femoral Artery (SFA) In-Stent Restenosis
Removable GORE VIABIL® Biliary Endoprosthesis for Treatment of Benign Biliary Strictures
BeFlared Versus VBX for FEVAR
TAVR vs SAVR in Severe Bicuspid Aortic Stenosis
GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study
PERIGON Japan Trial